Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, ...
Driven by domestic inflows and renewed optimism about a potential Fed rate cut in the September meeting, the market has ...
Indian Railway Finance Corporation Share Price216.3203:59 PM | 15 July 2024-1.12(-0.52%)One97 Communications Share Price469.6503:59 PM | 15 July 20243.7(0.8%)YES Bank ...
Chakri Lokapriya, Managing Partner, RSB LLP, says paint stocks at best are a trade because they have corrected very significantly ...
Stock market LIVE updates on May 14, 2024: Indian stock markets, which opened higher on Tuesday, were off highs ...
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura, who was in South San Francisco last ...
Granules India Ltd, part of the pharma space, has rallied more than 20% in the last 3 months to hit ...
Copyright © 2024 EuroAsia24 News.
EuroAsia24 News is not responsible for the content of external sites.